During the past decade, Arkansas Gastroenterology conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 27 clinical trials were completed, i.e. on average, 56.3% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 22 clinical trials were completed. i.e. 95.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arkansas Gastroenterology" #1 sponsor was "Celgene" with 6 trials, followed by "Allergan" with 4 trials sponsored, "Ironwood Pharmaceuticals, Inc." with 4 trials sponsored, "Madrigal Pharmaceuticals, Inc." with 4 trials sponsored and "Phathom Pharmaceuticals, Inc." with 4 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arkansas Gastroenterology" #1 collaborator was "Allergan Sales, LLC" with 2 trials as a collaborator, "RTI Health Solutions" with 2 trials as a collaborator, "DSM Nutritional Products, Inc." with 1 trials as a collaborator, "Premier Research Group plc" with 1 trials as a collaborator and "Sucampo AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Arkansas Gastroenterology" are "Irritable Bowel Syndrome" (6 trials), "Gastroparesis" (4 trials), "Nonalcoholic Steatohepatitis" (4 trials), "Colorectal Cancer" (3 trials) and "Crohn Disease" (3 trials). Many other conditions were trialed in "Arkansas Gastroenterology" in a lesser frequency.

Most popular intervention types in "Arkansas Gastroenterology" are "Drug" (54 trials), "Other" (7 trials), "Combination Product" (2 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (33 trials), "Ozanimod" (4 trials), "Vonoprazan" (4 trials), "Resmetirom" (3 trials) and "SEL" (3 trials). Other intervention names were less common.

The vast majority of trials in "Arkansas Gastroenterology" are 57 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Arkansas Gastroenterology". undefined are not yet recruiting, 12 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Arkansas Gastroenterology, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Arkansas Gastroenterology, 0 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".